An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD
Public ClinicalTrials.gov record NCT07670702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Open-Label Extension Study to Assess the Long-term Safety and Efficacy of TSND-201 for the Treatment of PTSD
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is evaluating the long-term safety and efficacy of TSND-201 in adults with PTSD. Participants that have completed a double-blind clinical trial with TNSD-201 for PTSD will be invited to participate in this open-label extension trial. Each participant will be able to receive up to three Treatment Courses over the duration of the study (up to 48 weeks). Each Treatment Course includes 4 dosing sessions, spaced one week apart.
Study identification
- NCT ID
- NCT07670702
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 22, 2026 (Actual)
- Primary completion
- Dec 2028 (Estimated)
- Completion
- Jan 2029 (Estimated)
- Last update posted
- Sep 4, 2026
2026 – 2029
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Preferred Research Partners | Little Rock | Arkansas | 72211 | — |
| CalNeuro Research Group | Los Angeles | California | 90025 | — |
| Catalina Research Institute | Montclair | California | 91763 | — |
| Starlight Clinical Research | Evergreen | Colorado | 80439 | — |
| Clinical Neuroscience Solutions - Jacksonville | Jacksonville | Florida | 32256 | — |
| Segal Trials | Lauderhill | Florida | 33319 | — |
| Accel Clinical Research | Maitland | Florida | 32751 | — |
| CNS Healthcare | Orlando | Florida | 32801 | — |
| Vitalix Clinical | Worcester | Massachusetts | 01608 | — |
| Arch Clinical Trials | Creve Coeur | Missouri | 63141 | — |
| Bio Behavioral Health | Toms River | New Jersey | 08755 | — |
| Insight Clinical Trials | Independence | Ohio | 44131 | — |
| Flourish Research | Plymouth Meeting | Pennsylvania | 19462 | — |
| Austin Clinical Trial Partners | Austin | Texas | 78737 | — |
| Haracec Clinical Research | El Paso | Texas | 79902 | — |
| Cedar Clinical Research | Draper | Utah | 84020 | — |
| Inner Space Research | Orem | Utah | 84058 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07670702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 4, 2026 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07670702 live on ClinicalTrials.gov.